Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Equity Ratio (2022 - 2025)

Gossamer Bio's Equity Ratio history spans 4 years, with the latest figure at 0.71 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 861.92% year-over-year to 0.71; the TTM value through Dec 2025 reached 0.71, down 861.92%, while the annual FY2025 figure was 0.71, 861.92% down from the prior year.
  • Equity Ratio reached 0.71 in Q4 2025 per GOSS's latest filing, down from 0.39 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.3 in Q3 2023 to a low of 0.71 in Q4 2025.
  • Average Equity Ratio over 4 years is 0.03, with a median of 0.07 recorded in 2024.
  • Peak YoY movement for Equity Ratio: soared 353.98% in 2023, then plummeted 861.92% in 2025.
  • A 4-year view of Equity Ratio shows it stood at 0.04 in 2022, then skyrocketed by 353.98% to 0.2 in 2023, then tumbled by 53.52% to 0.09 in 2024, then plummeted by 861.92% to 0.71 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Equity Ratio are 0.71 (Q4 2025), 0.39 (Q3 2025), and 0.19 (Q2 2025).